OBJECTIVE: To compare neonatal red blood cell (RBC) transfusion rates in four large Intermountain Healthcare NICUs, all of which adhere to the same RBC transfusion guidelines. STUDY DESIGN: This retrospective analysis was part of a transfusion-management quality-improvement project. De-identified data included RBC transfusions, clinical and laboratory findings, the anemia-prevention strategies in place in each NICU, and specific costs and outcomes. RESULT: Of 2389 NICU RBC transfusions given during the 4-year period studied, 98.9 ± 2.1% (mean ± S.D.) were compliant with our transfusion guidelines, with no difference in compliance between any of the four NICUs. However, RBC transfusion rates varied widely between the four, with averages ranging from 4.6 transfusions/1000 NICU days to 21.7/1000 NICU days (P < 0.00001). Gestational age-adjusted transfusion rates were correspondingly discordant (P < 0.00001). The lower-transfusing NICUs had written anemia-preventing guidelines, such as umbilical cord milking at very low birth weight delivery, use of cord blood for admission laboratory studies, and darbepoetin dosing for selected neonates. Rates of Bell stage ⩾ 2 necrotizing enterocolitis and grade ⩾ 3 intraventricular hemorrhage were lowest in the two lower-transfusing NICUs (P < 0.0002 and P < 0.0016). Average pharmacy costs for darbepoetin were $84/dose, with an average pharmacy cost of $269 per transfusion averted. With a cost of $900/RBC transfusion, the anemia-preventing strategies resulted in an estimated cost savings to Intermountain Healthcare of about $6970 per 1000 NICU days, or about $282,300 annually. CONCLUSION: Using transfusion guidelines has been shown previously to reduce practice variability, lower transfusion rates and diminish transfusion costs. Based on our present findings, we maintain that even when transfusion guidelines are in place and adhered to rigorously, RBC transfusion rates are reduced further if anemia-preventing strategies are also in place.
OBJECTIVE: To compare neonatal red blood cell (RBC) transfusion rates in four large Intermountain Healthcare NICUs, all of which adhere to the same RBC transfusion guidelines. STUDY DESIGN: This retrospective analysis was part of a transfusion-management quality-improvement project. De-identified data included RBC transfusions, clinical and laboratory findings, the anemia-prevention strategies in place in each NICU, and specific costs and outcomes. RESULT: Of 2389 NICU RBC transfusions given during the 4-year period studied, 98.9 ± 2.1% (mean ± S.D.) were compliant with our transfusion guidelines, with no difference in compliance between any of the four NICUs. However, RBC transfusion rates varied widely between the four, with averages ranging from 4.6 transfusions/1000 NICU days to 21.7/1000 NICU days (P < 0.00001). Gestational age-adjusted transfusion rates were correspondingly discordant (P < 0.00001). The lower-transfusing NICUs had written anemia-preventing guidelines, such as umbilical cord milking at very low birth weight delivery, use of cord blood for admission laboratory studies, and darbepoetin dosing for selected neonates. Rates of Bell stage ⩾ 2 necrotizing enterocolitis and grade ⩾ 3 intraventricular hemorrhage were lowest in the two lower-transfusing NICUs (P < 0.0002 and P < 0.0016). Average pharmacy costs for darbepoetin were $84/dose, with an average pharmacy cost of $269 per transfusion averted. With a cost of $900/RBC transfusion, the anemia-preventing strategies resulted in an estimated cost savings to Intermountain Healthcare of about $6970 per 1000 NICU days, or about $282,300 annually. CONCLUSION: Using transfusion guidelines has been shown previously to reduce practice variability, lower transfusion rates and diminish transfusion costs. Based on our present findings, we maintain that even when transfusion guidelines are in place and adhered to rigorously, RBC transfusion rates are reduced further if anemia-preventing strategies are also in place.
Authors: D A Calhoun; R D Christensen; C S Edstrom; S E Juul; R K Ohls; K R Schibler; M C Sola; S E Sullivan Journal: Clin Perinatol Date: 2000-09 Impact factor: 3.430
Authors: R Singh; P F Visintainer; I D Frantz; B L Shah; K M Meyer; S A Favila; M S Thomas; D M Kent Journal: J Perinatol Date: 2011-01-27 Impact factor: 2.521
Authors: Peg C Nopoulos; Amy L Conrad; Edward F Bell; Ronald G Strauss; John A Widness; Vincent A Magnotta; M Bridget Zimmerman; Michael K Georgieff; Scott D Lindgren; Lynn C Richman Journal: Arch Pediatr Adolesc Med Date: 2011-01-03
Authors: Terri Marin; James Moore; Niki Kosmetatos; John D Roback; Paul Weiss; Melinda Higgins; Linda McCauley; Ora L Strickland; Cassandra D Josephson Journal: Transfusion Date: 2013-03-11 Impact factor: 3.157
Authors: K M Shannon; J F Keith; W C Mentzer; R A Ehrenkranz; M S Brown; J A Widness; C A Gleason; E M Bifano; D D Millard; C B Davis Journal: Pediatrics Date: 1995-01 Impact factor: 7.124
Authors: B C MacQueen; R D Christensen; C C Yost; D K Lambert; V L Baer; M J Sheffield; P V Gordon; M J Cody; E Gerday; R Schlaberg; J Lowe; J G Shepherd Journal: J Perinatol Date: 2016-07-07 Impact factor: 2.521
Authors: Minesh Khashu; Christof Dame; Pascal M Lavoie; Isabelle G De Plaen; Parvesh M Garg; Venkatesh Sampath; Atul Malhotra; Michael D Caplan; Praveen Kumar; Pankaj B Agrawal; Giuseppe Buonocore; Robert D Christensen; Akhil Maheshwari Journal: Newborn (Clarksville) Date: 2022-03-31
Authors: Sandra E Juul; Phuong T Vu; Bryan A Comstock; Rajan Wadhawan; Dennis E Mayock; Sherry E Courtney; Tonya Robinson; Kaashif A Ahmad; Ellen Bendel-Stenzel; Mariana Baserga; Edmund F LaGamma; L Corbin Downey; Michael O'Shea; Raghavendra Rao; Nancy Fahim; Andrea Lampland; Ivan D Frantz; Janine Khan; Michael Weiss; Maureen M Gilmore; Robin Ohls; Nishant Srinivasan; Jorge E Perez; Victor McKay; Patrick J Heagerty Journal: JAMA Pediatr Date: 2020-10-01 Impact factor: 16.193
Authors: Emma Persad; Greta Sibrecht; Martin Ringsten; Simon Karlelid; Olga Romantsik; Tommy Ulinder; Israel Júnior Borges do Nascimento; Maria Björklund; Anneliese Arno; Matteo Bruschettini Journal: PLoS One Date: 2021-02-08 Impact factor: 3.240